← Eichor
Study identifier: NCT07203742 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Effect of Mandala on Anxiety and Fear Levels in Children With Leukemia Before Intrathecal Chemotherapy Treatment

Condition: Acute Lymphoblastic Leukemia · Childhood Acute Leukemia · Acute Myeloblastic Leukaemia  ·  Sponsor: Ege University

PhaseNA
Planned participants60
Who can joinAll sexes, 4 Years to 12 Years
Healthy volunteersNo

About this study

This study aims to examine the effect of mandala coloring activity, administered before intrathecal chemotherapy treatment in children with leukemia, on pre-procedure anxiety and fear in children. The main question this study aims to answer is: Does mandala coloring administered before intrathecal chemotherapy treatment reduce pre-procedure anxiety and fear in children with leukemia? Descriptive demographic data will be collected from the children who will be given mandalas. Data will be collected using an Anxiety Scale and a Fear Scale.

This description comes directly from the study's public registry record.

Talk to the study team

Seda ARDAHAN SEVGİLİ, Ph.D  ·  00902323115572  ·  sedardahan@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Ege University Childrens HospitalIzmir, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07203742